Ethamsylate Tablet Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 250 mg, 500 mg

Reference Brands: Dicynone (USA/EU), Dicynene (India),

Category: Women's Health

Ethamsylate is used in the treatment of bleeding. It is used to prevent or reduce bleeding in conditions like abnormal blood loss during periods and dysfunctional uterine bleeding. It also prevents or reduces bleeding during, before or after delicate surgeries. Ethamsylate is a haemostatic medication. Ethamsylate Tablet is available in Tablets and strengths such as 250 mg, 500 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ethamsylate Tablet is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Ethamsylate Tablet can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Etamsylate (also spelled ethamsylate) is a hemostatic or anti-hemorrhagic agent widely used to prevent and control bleeding in various clinical conditions. It primarily acts on the microcirculation by improving the stability and resistance of capillary walls, thereby reducing abnormal bleeding. The drug enhances platelet adhesion and supports the formation of an effective hemostatic plug without significantly affecting the overall coagulation cascade.

One of the key mechanisms of etamsylate is its ability to inhibit the biosynthesis and activity of certain prostaglandins that are responsible for platelet disaggregation, vasodilation, and increased capillary permeability. By reducing these effects, etamsylate helps maintain vascular integrity and minimizes blood loss. It is commonly used in conditions such as menorrhagia (heavy menstrual bleeding), perioperative bleeding, dental procedures, and other situations involving fragile capillaries.

Etamsylate is generally well tolerated and can be administered in both oral and injectable forms depending on the clinical need. Its targeted action on capillaries and platelets makes it a valuable option for managing bleeding disorders where capillary fragility is a major concern.